News Conference News ACC 2019 ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend Shelley Wood March 11, 2019
News Daily News Final Phase III Bempedoic Acid Trial Proves Positive for LDL-Lowering Shelley Wood October 29, 2018
News Daily News Bempedoic Acid Phase III Trial Meets Primary Endpoint for Cutting LDL Cholesterol Yael L. Maxwell March 08, 2018
News Industry News Esperion Therapeutics Announces Positive Top-Line Phase 2 Results for ETC-1002 in Patients With Hypercholesterolemia and Hypertension July 28, 2015